Stroke prevention in atrial fibrillation: Can we do better?

Deirdre Lane, Gregory Lip

Research output: Contribution to journalBook/Film/Article reviewpeer-review

1 Citation (Scopus)
111 Downloads (Pure)

Abstract

Clinical guidelines advocate oral anticoagulation (OAC) for stroke prevention in patients with atrial fibrillation and ≥1 risk factors for stroke, but 40% of eligible patients receive aspirin, and those at greatest risk are least likely to be prescribed OAC. Why is there a discrepancy between guidelines and clinical practice?
Original languageEnglish
JournalNature Reviews Cardiology
Early online date28 Jul 2016
DOIs
Publication statusE-pub ahead of print - 28 Jul 2016

Fingerprint

Dive into the research topics of 'Stroke prevention in atrial fibrillation: Can we do better?'. Together they form a unique fingerprint.

Cite this